Last reviewed · How we verify
NCT01834612
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw
Phase 1 trial testing CM1500 in Blood Loss in 20 participants. Completed in 11 March 2013.
11 March 2013
Quick facts
| Lead sponsor | Zynex Monitoring Solutions |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 20 |
| Start date | 7 January 2013 |
| Primary completion | 11 March 2013 |
| Estimated completion | 11 March 2013 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CM1500
Conditions studied
- Blood Loss — all drugs for Blood Loss →
Sponsor
Zynex Monitoring Solutions
Who can join
Adults 18 to 50, any sex, with Blood Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine if a manual blood loss can be detected using the non-invasive blood monitor.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01834612
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Blood Loss
Currently open trials in the same condition.
- NCT07526311 — Reducing Blood Loss During Myomectomy:Uterine Artery Ligation Vs Pericervical Tourniquet · NA · recruiting
- NCT07089251 — The Perioperative Outcome of Epinephrine Infusion and Tranexamic Acid in Knee Arthroplasty Surgery · Phase 4 · recruiting
- NCT05488457 — Oxytocin Pharmacokinetics and Pharmacodynamics · Phase 2 · recruiting
- NCT06802874 — Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy · recruiting
- NCT06903299 — Prospective Investigation of Intra-Articular Tranexamic Acid Use in Elective Hip Arthroplasty · recruiting
Other Zynex Monitoring Solutions trials
Trials by the same sponsor.
- NCT05980013 — Evaluation of Physiological Variables and Detection of Blood Loss in Healthy Adults With Different Subject Positioning b · NA · completed
- NCT05740644 — Clinical Evaluation of the Zynex Monitoring System, Model CM-1600 · NA · completed
- NCT05463198 — Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600 · NA · completed
- NCT05125848 — Clinical Evaluation of the CM-1500 During Hemodialysis · NA · completed
- NCT05012462 — Clinical Evaluation of the CM-1500 During Apheresis Blood Donation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01834612 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zynex Monitoring Solutions
- Last refreshed: 21 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01834612.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing